Глобальная карта > Инновации > East Asia > China > TianJin > CanSino Biologics
CanSino Biologics icon
CanSino Biologics Inc.’s experimental coronavirus vaccine has an efficacy rate of 65.7% at preventing symptomatic cases based on an analysis from late-stage trials, adding a one-shot candidate to the world’s growing arsenal against Covid-19.
Loading startups...